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Review question
The aim of this systematic review is to critically appraise, synthesise and present the available evidence on
experiences with the implementation of Medication Reviews (MR) in ambulatory care settings including
potential facilitators and barriers, regardless of implementation status. 
The CFIR (Consolidated Framework for Implementation Research) will be used to guide the review and to
identify facilitators and barriers at all stages of the implementation process.
The specific review questions are
1. What are the experiences, perceptions, attitudes, views and beliefs stakeholders (e.g. pharmacists, health
professionals, general public, patients, policy makers etc.) have gained with implementation of medication
reviews in ambulatory care settings?
2. Which barriers and facilitators have been identified in the implementation of pharmacist's medication
reviews into ambulatory care settings?
 
Searches
The systematic review will be carried out according to the PRISMA guidelines in the following databases:
Cumulative Index to Nursing and Allied Health Literature (CINAHL), MEDLINE, The Cochrane Library,
International Pharmaceutical Abstracts (IPA), Scopus. The search will include publications in the German,
Spanish and English language. 
We will apply a three-step search strategy: An orientating search will be conducted in MEDLINE and IPA
using the key search terms: “implementation”, “pharmac*”, [“medication review” OR “medication
management”], “facilitat*”, “barrier*”. The titles, abstracts and index terms of the retrieved papers will be
screened for additional search terms. These will be used in the third step, the search in all databases named
above. Furthermore, manual searches of related studies listed in the reference, footnote and citations will be
carried out to include more relevant papers.
Only peer reviewed papers and primary research items will be included. We will exclude opinion articles,
editorials and narrative reports.
 
Types of study to be included
This review will consider studies with quantitative, qualitative and mixed methods.
 
Condition or domain being studied
Implementation of Medication Reviews carried out by pharmacists in community pharmacy and other
ambulatory health care settings. We will understand the term “Medication Review” according to the PCNE
2017 definition: “Medication review is a structured evaluation of a patient's medicines with the aim of
optimising medicines use and improving health outcomes. This entails detecting drug related problems and
recommending interventions.”
 
Participants/population
All stakeholders, including pharmacists, other health professionals, policy makers and patients, whose
experiences, views, beliefs, attitudes are described in the studies included.
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Intervention(s), exposure(s)
Implementation of Medication Reviews (Medication Reviews according to the PCNE definition).
 
Comparator(s)/control
Not applicable.
 
Context
 
Main outcome(s)
• experiences of stakeholders such as views, perceptions, opinions, attitudes, beliefs, thoughts, feelings,
impressions, stances, viewpoints, standpoints and positions of the implementation process. 
• facilitators and barriers to the implementation of pharmacist's medication reviews in community pharmacies
and other ambulatory health care settings.
 
Additional outcome(s)
None.
 
Data extraction (selection and coding)
The identification, screening, eligibility and inclusion of papers will be performed and presented according to
the Prisma -P 2015 Checklist and the Prisma 2009 flow diagram. 
The extraction tools will be designed according to the objectives in this systematic review. The CFIR
domains will be used to sort the experiences and to guide the identification of differing types of barriers and
facilitators.
 
Risk of bias (quality) assessment
Quality assessment will be conducted on all included manuscripts by two independent reviewers using the
Mixed Methods Appraisal Tools (MMAT, Pluye et.al. 2011). Disagreements will be resolved by consensus
after discussion with the research team.
 
Strategy for data synthesis
Only papers with sufficient methodological quality (according to MMAT) will be included in this review. First
all included papers will be tabulated, indicating also their quality and risk of bias. Where possible, quantitative
data findings will be pooled for studies using similar outcome measures and population statistics and
analysed using statistical meta-analysis. To judge the heterogeneity of the studies we will use the ?²-test, to
assess the effect size of categorical data we will calculate the Odds Ratio and for continuous data weighted
mean differences (IBM SPSS Statistic for Windows, Armonk, NY, USA). If heterogeneity of the studies does
not allow statistical pooling, we will report the findings narratively supported by tables and figures, where
appropriate.
Results from qualitative papers will be aggregated and assessed within their respective domain of the
consolidated framework for implementation research (CFIR) (I: Intervention characteristics; II: Outer setting;
III: Inner setting; IV: Characteristic of individuals; V: Process); this will be reported as narrative synthesis,
also supported by tables and figures. The CFIR will provide the framework for grouping experiences with
implementation as well as facilitators and barriers to implementation in the format of a “thematic analysis”.
The data synthesis will be performed by two researchers independently, discrepancies will be discussed and
where necessary solved within the entire team.
 
Analysis of subgroups or subsets
None planned.
 
Contact details for further information
Dorothee Michel
d.michel@rgu.ac.uk
 
Organisational affiliation of the review
Robert Gordon University, Aberdeen, Scotland
                               Page: 2 / 4
PROSPERO
International prospective register of systematic reviews
https://www.rgu.ac.uk/
 
Review team members and their organisational affiliations
Ms Dorothee Michel. Robert Gordon University, Aberdeen Scotland
Professor Derek Stewart. Robert Gordon University, Aberdeen Scotland
Dr Anita Weidmann. Robert Gordon University, Aberdeen Scotland
 
Type and method of review
Narrative synthesis, Systematic review
 
Anticipated or actual start date
01 February 2019
 
Anticipated completion date
31 December 2019
 
Funding sources/sponsors
None
 
Conflicts of interest
 
Language
English
 
Country
Scotland
 
Stage of review
Review Ongoing
 
Subject index terms status
Subject indexing assigned by CRD
 
Subject index terms
Ambulatory Care; Humans; Medication Therapy Management; Pharmacists; Research
 
Date of registration in PROSPERO
06 February 2019
 
Date of publication of this version
06 February 2019
 
Details of any existing review of the same topic by the same authors
 
Stage of review at time of this submission
 
Stage Started Completed
Preliminary searches Yes No
Piloting of the study selection process No No
Formal screening of search results against eligibility criteria No No
Data extraction No No
Risk of bias (quality) assessment No No
Data analysis No No
 
                               Page: 3 / 4
PROSPERO
International prospective register of systematic reviews
Versions
06 February 2019
PROSPERO
This information has been provided by the named contact for this review. CRD has accepted this information in good
faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission
is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any
associated files or external websites. 
                               Page: 4 / 4
